NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-5

Scientific Publications

Related Web Sites

Medical Search Engines

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol B-26
A Randomized Trial in Patients with Metastatic or Locally Advanced Breast Cancer Comparing the Effect of 3-Hour vs 24-Hour Infusion of High-Dose Taxol

Specific Aims
The primary aim of this trial is to compare the response rates of metastatic or locally advanced breast cancer with administration of high-dose Taxol given as 3-hour infusion to the response rates when given as 24-hour infusion. Secondary aims are to compare the two durations of infusion with respect to toxicity, relapse, and survival. If there are no differences in efficacy, the less toxic infusion regimen will be preferable. If there are no differences in toxicity and efficacy, the 3-hour infusion will be preferable.